Drug Shortage Report for VOLUVEN
| Report ID | 147737 |
| Drug Identification Number | 02278057 |
| Brand name | VOLUVEN |
| Common or Proper name | Voluven® (6% hydroxyethyl starch 130/0.4 in 0.9% sodium chloride injection) 500 mL |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROXYETHYL STARCH 130/0.4 |
| Strength(s) | 6% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500mL |
| ATC code | B05AA |
| ATC description | BLOOD AND RELATED PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-10-27 |
| Actual start date | 2021-10-27 |
| Estimated end date | 2021-12-14 |
| Actual end date | 2021-12-14 |
| Shortage status | Resolved |
| Updated date | 2021-12-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v19 | 2021-12-16 | French | Compare |
| v18 | 2021-12-16 | English | Compare |
| v17 | 2021-12-09 | French | Compare |
| v16 | 2021-12-09 | English | Compare |
| v15 | 2021-12-06 | French | Compare |
| v14 | 2021-12-06 | English | Compare |
| v13 | 2021-12-03 | French | Compare |
| v12 | 2021-12-03 | English | Compare |
| v11 | 2021-12-01 | French | Compare |
| v10 | 2021-12-01 | English | Compare |
| v9 | 2021-11-19 | French | Compare |
| v8 | 2021-11-19 | English | Compare |
| v7 | 2021-11-16 | French | Compare |
| v6 | 2021-11-16 | English | Compare |
| v5 | 2021-10-28 | French | Compare |
| v4 | 2021-10-27 | French | Compare |
| v3 | 2021-10-27 | English | Compare |
| v2 | 2021-10-21 | French | Compare |
| v1 | 2021-10-21 | English | Compare |
Showing 1 to 19 of 19